Ja. Mordente et al., THE EFFECTS OF BREFELDIN-A (BFA) ON CELL-CYCLE PROGRESSION INVOLVING THE MODULATION OF THE RETINOBLASTOMA PROTEIN (PRB) IN PC-3 PROSTATE-CANCER CELLS, The Journal of urology, 159(1), 1998, pp. 275-279
Purpose: To investigate the effects of brefeldin A (BFA) on the growth
of the androgen-independent human prostate cancer PC-3 cells, focusin
g on cell cycle regulation. Materials and Methods: BFA is a fungal mac
rocyclic lactone with an antiviral activity. PC-3 cells were cultured
with various concentrations of BFA for indicated times and cell growth
was monitored at each time point. Cell cycle analysis was performed t
o explore the mechanism of PEA-induced growth inhibition. To further i
nvestigate the cell cycle regulation, cell cycle-controlling factors,
such as the retinoblastoma gene product (pRB) and its regulatory compo
nents cdk2, cdk4, and cyclin D-1, were analyzed by Western immunoblots
. Results: BFA was a potent growth inhibitor at a concentration of 30
ng./ml., resulting in a >70% reduction in cell number at 3 days. Cell
cycle analysis revealed a cell arrest in the G(1) to S phase transitio
n. Western blots further showed that BFA induced dephosphorylation of
pRB accompanied by down regulation of cdk2, cdk4, and cyclin D-1 expre
ssion. The extended pRB dephosphorylation in control cell lysates was
also observed by the addition of BFA-treated lysates, but was prevente
d by the inclusion of phosphatase inhibitors in assay mixtures. Conclu
sion: These results suggest that BFA may be a potent cell cycle modula
tor, which post-translationally regulates pRB phosphorylation possibly
by down-regulating cdk2, cdk4, and cyclin D-1 and/or by up-regulating
a phosphatase(s) capable of dephosphorylating pRB. Thus, BFA-induced
growth inhibition in PC-3 cells appears to be at least partially due t
o the modulation of a pRB-mediated growth pathway.